Search
Design Therapeutics Inc
DSGNAdd to Watchlist
15.640USD
+0.980+6.68%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
976.58MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Design Therapeutics Inc is 5.00, ranking 132 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 61.89%, representing a quarter-over-quarter decrease of 8.26%. The largest institutional shareholder is Steven Cohen, holding a total of 2.61M shares, representing 4.36% of shares outstanding, with 14.84% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
Ansari (Aseem Z. Ph.D.)
SR One Capital Management, LP
Light Irrevocable Trust.
Star Irrevocable Trust.
Quan Venture Fund II LP
Logos Global Management LP
Baker Bros. Advisors LP
BlackRock Institutional Trust Company, N.A.
Vivo Capital, LLC
1
2